Literature DB >> 33654902

Measuring Small-molecule Inhibition of Protein Interactions in Live Cells Using FLIM-FRET.

James M Pemberton1,2, Qian Liu1, David W Andrews1,2.   

Abstract

This protocol was designed to quantitatively measure small-molecule displacement of proteins in live mammalian cells using fluorescence lifetime imaging microscopy-Förster resonance energy transfer (FLIM-FRET). Tumour cell survival is often dependent on anti-apoptotic proteins, which bind to and inhibit pro-apoptotic proteins, thus preventing apoptosis. Small-molecule inhibitors that selectively target these proteins (termed BH3-mimetics) are therefore a promising avenue for the treatment of several cancers. Previous techniques used to study the efficacy of these drugs often use truncated versions of both pro- and anti-apoptotic proteins, as they are membrane bound and hydrophobic in nature. As a result, the true efficacy of these drugs to displace full-length pro-apoptotic proteins in their native environment within a cell is poorly understood. This protocol describes FLIM-FRET methods to directly measure the displacement (or lack of displacement) of full-length Bcl-2 family proteins in live mammalian cells.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Apoptosis; BH3-mimetic; Bad; Bcl-2; Bcl-XL; Displacement; FLIM; FRET; Live cell; Resistance

Year:  2019        PMID: 33654902      PMCID: PMC7853989          DOI: 10.21769/BioProtoc.3401

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

Review 1.  Monitoring protein interactions in living cells with fluorescence lifetime imaging microscopy.

Authors:  Yuansheng Sun; Nicole M Hays; Ammasi Periasamy; Michael W Davidson; Richard N Day
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

2.  Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.

Authors:  Jonathan F Lovell; Lieven P Billen; Scott Bindner; Aisha Shamas-Din; Cecile Fradin; Brian Leber; David W Andrews
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

3.  Rapid Imaging of BCL-2 Family Interactions in Live Cells Using FLIM-FRET.

Authors:  Elizabeth J Osterlund; Nehad Hirmiz; Christian Tardif; David W Andrews
Journal:  Methods Mol Biol       Date:  2019

4.  Nonionic detergents induce dimerization among members of the Bcl-2 family.

Authors:  Y T Hsu; R J Youle
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

5.  The use of FLIM-FRET for the detection of mitochondria-associated protein interactions.

Authors:  Elizabeth J Osterlund; Qian Liu; David W Andrews
Journal:  Methods Mol Biol       Date:  2015

6.  Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance.

Authors:  Jessie Pécot; Laurent Maillet; Janic Le Pen; Céline Vuillier; Sophie de Carné Trécesson; Aurélie Fétiveau; Kristopher A Sarosiek; Florian J Bock; Frédérique Braun; Anthony Letai; Stephen W G Tait; Fabien Gautier; Philippe P Juin
Journal:  Cell Rep       Date:  2016-12-20       Impact factor: 9.423

7.  Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.

Authors:  Alexander Aranovich; Qian Liu; Tony Collins; Fei Geng; Sudeepa Dixit; Brian Leber; David W Andrews
Journal:  Mol Cell       Date:  2012-03-30       Impact factor: 17.970

8.  Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2.

Authors:  Qian Liu; Elizabeth J Osterlund; Xiaoke Chi; Justin Pogmore; Brian Leber; David William Andrews
Journal:  Elife       Date:  2019-03-12       Impact factor: 8.140

9.  Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET.

Authors:  Qian Liu; Brian Leber; David W Andrews
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

10.  Bcl-XL inhibits membrane permeabilization by competing with Bax.

Authors:  Lieven P Billen; Candis L Kokoski; Jonathan F Lovell; Brian Leber; David W Andrews
Journal:  PLoS Biol       Date:  2008-06-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.